Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
12
1kṀ3172026
73%
chance
1H
6H
1D
1W
1M
ALL
Resolves to YES if a statistically significant difference in lifespan between any treatment group and every control group is shown in any scientific journal article published by the Dog Aging Project team as a result of their ongoing non-clinical trial(s) in dogs.
Resolves to NO if this does not happen by 31 DEC 2026.
Link to DAP: https://dogagingproject.org/
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Does rapamyacin significantly increase the lifespan of dogs?
71% chance
Will the Rapamycin - Effects on Alzheimer's and Cognitive Health (REACH) trial show that Rapamycin improves Alzheimer's
26% chance
What percent of those taking rapamycin to slow aging will comment a positive or neutral review?
56% chance
Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?
43% chance
What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
What will be the next compound tested by the Interventions Testing Program (ITP) shown to have a statistically significant effect on lifespan?
What will be the next compound produced and tested by the ITP that will be shown to have a statistically significant effect on both median and 90th percentile lifespan?
Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
32% chance
Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
32% chance
By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?